Bioxcel Therapeutics Stock Forecast

Buy or Hold candidate since Jun 16, 2026 Gain 8.33%

The BioXcel Therapeutics Inc. stock price gained 8.33% on the last trading day (Monday, 22nd Jun 2026), rising from $1.20 to $1.30. During the last trading day the stock fluctuated 8.33% from a day low at $1.20 to a day high of $1.30. The price has risen in 7 of the last 10 days and is up by 17.65% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 359 thousand more shares were traded than the day before. In total, 775 thousand shares were bought and sold for approximately $1.01 million.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $1.29, a level that may pose a second chance to hit a runner. According to fan-theory $1.61 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

BTAI Signals & Forecast

The BioXcel Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.19 and $1.18. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). BioXcel Therapeutics Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, May 27, 2026, and so far it has fallen -0.763%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for BioXcel Therapeutics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.22 and $1.20. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, BioXcel Therapeutics Inc. finds support just below today's level at $1.22. If this is broken, then the next support from accumulated volume will be at $1.20 and $1.15.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.100 between high and low, or 8.33%. For the last week, the stock has had daily average volatility of 6.84%.

Our recommended stop-loss: $1.25 (-3.83%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 17 days ago.)

Trading Expectations (BTAI) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect BioXcel Therapeutics Inc. to open at $1.27, and during the day (based on 14 day Average True Range), to move between $1.26 and $1.34, which gives a possible trading interval of +/-$0.0815 (+/-6.47%) up or down from last closing price. If BioXcel Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 6.47% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.31 (0.77%) than the support at $1.22 (6.15%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is BioXcel Therapeutics Inc. stock A Buy?

Several short-term signals are positive and the break-up from the falling trend indicates a possible shift for a trend. We believe that the prices around the breaking point will indicate particularly good levels, but we also believe that the current level will hold a possible good buy level for the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 1.658 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $1.27 ( 2.56%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk